peripheral nervous system disease: A disease involving the peripheral nervous system.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
213 |
4. Check minimum number of eventsNone |
213 |
5. Include endpointsNone |
213 |
6. Filter based on genotype QC (FinnGen only) |
213 |
Control definitions (FinnGen only)
- Control exclude
- G6_POLYNEU
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- G60-G64
- Name in latin
- Aliae morbositates systematis nervosi peripherici
Similar endpoints
↥List of similar endpoints to
Other disorders of peripheral nervous system
based on the number of shared cases.
Similar with more cases:
- Polyneuropathies and other disorders of the peripheral nervous system
- Neurological diseases
- Neurological diseases, wide definition
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1252 | 584 | 661 |
| Only index persons | 1109 | 536 | 573 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 59.48 | 59.38 | 59.73 |
| Only index persons | 57.53 | 58.02 | 57.07 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 213 | 116 | 97 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 58.80 | 56.40 | 61.66 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 194
- Matched controls
- 1941
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G64
ICD-10 Finland
Other disorders of peripheral nervous system
+∞
277.5
193
*
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
226.9
37.2
37
*
N03AX12
ATC
gabapentin; oral
5.9
21.2
68
163
N03AX16
ATC
pregabalin; oral
4.6
18.9
80
255
G62.8
ICD-10 Finland
Other specified polyneuropathies
+∞
13.7
13
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
6.2
12.0
33
62
TAB00
NOMESCO Finland
Lumbar puncture
8.7
11.3
24
31
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
6.1
10.6
29
54
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.6
8.9
89
477
N02AX02
ATC
tramadol; systemic, rectal
2.5
8.8
98
557
N06AX21
ATC
duloxetine; oral
3.9
8.5
36
107
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
4.3
8.5
32
86
N03AE01
ATC
clonazepam; systemic
5.8
8.3
23
44
M48.0
ICD-10 Finland
Spinal stenosis
3.8
7.5
32
96
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
14.1
7.5
12
9
R20.2
ICD-10 Finland
Paraesthesia of skin
4.8
7.5
24
55
M54.2
ICD-10 Finland
Cervicalgia
4.7
7.3
24
56
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
5.3
7.2
21
43
L28
ICPC
Limited function/disability (L)
3.1
7.2
43
164
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.4
7.1
35
119
M79.6
ICD-10 Finland
Pain in limb
2.3
6.8
79
444
N06AA09
ATC
amitriptyline; systemic
3.4
6.7
32
106
N06AX11
ATC
mirtazapine; oral
2.3
6.4
72
395
G60.0
ICD-10 Finland
Hereditary motor and sensory neuropathy
+∞
6.3
6
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
27.6
6.3
8
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.7
6.2
26
78
R52.9
ICD-10 Finland
Pain, unspecified
3.6
6.1
27
84
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.7
6.0
25
74
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3004588) Protein electrophoresis panel - Serum or Plasma
52
109
5.99
24.94
3.3
3.0
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
50
107
5.80
23.37
2.4
2.5
—
5.7
—
0
6
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
45
92
5.93
22.01
1.3
1.3
—
25.3
—
0
8
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
16
15
11.45
14.82
1.2
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
60
5.66
14.80
3.5
1.7
g/l
9.1
10.6
0.79
23
52
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
15
13
12.34
14.58
1.1
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
65
5.41
14.53
3.6
1.7
g/l
4.7
3.7
0.39
22
48
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
65
5.41
14.53
3.6
1.7
g/l
6.8
7.4
1.03
22
52
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
31
65
5.41
14.53
3.6
1.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
62
5.47
14.28
3.7
1.7
g/l
2.8
3.3
2.10
22
49
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
14
13
11.46
12.99
1.2
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
123
684
2.89
12.97
2.4
1.9
pmol/l
96.4
95.1
0.11
69
343
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
104
540
2.81
12.34
2.6
2.0
u/l
200.6
198.8
0.01
96
505
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
21
38
6.02
11.41
1.2
1.2
e6/l
5.1
170.3
0.54
15
30
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
21
38
6.02
11.41
1.2
1.1
e6/l
1.5
2.6
0.83
15
27
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
15
7
22.90
10.84
1.2
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
19
34
6.04
10.42
1.2
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
51
204
2.97
9.54
1.3
1.3
titre
406.7
597.7
—
6
52
(3024561) Albumin [Mass/volume] in Serum or Plasma
122
753
2.45
9.34
6.0
4.3
g/l
35.6
35.6
0.02
114
707
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
125
781
2.45
9.30
11.8
5.9
mmol/l
1.2
1.2
0.18
117
702
(3012095) Magnesium [Moles/volume] in Serum or Plasma
59
267
2.67
8.69
4.4
3.4
mmol/l
0.8
0.8
1.33
53
246
(42870588) Differential panel, method unspecified - Blood
99
573
2.36
8.56
6.6
5.1
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
134
885
2.39
8.50
6.7
5.4
e9/l
1.7
1.9
0.84
119
778
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
130
851
2.35
8.37
8.1
7.0
mmol/l
1.2
1.2
0.33
112
715
(3006315) Basophils [#/volume] in Blood
131
867
2.33
8.13
6.7
5.4
e9/l
0.0
0.0
0.27
115
742
(21494890) Protein electrophoresis panel - 24 hour Urine
12
17
7.42
8.08
1.8
4.0
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
130
864
2.30
7.90
6.7
5.4
e9/l
0.6
0.6
0.02
115
738
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
71
369
2.39
7.70
1.3
1.2
u/ml
1.9
1.5
0.09
11
101
(3013650) Neutrophils [#/volume] in Blood by Automated count
144
1006
2.33
7.67
10.6
10.1
e9/l
4.2
4.1
0.35
130
876
(3013115) Eosinophils [#/volume] in Blood
132
895
2.25
7.48
6.9
5.8
e9/l
0.2
0.2
0.91
119
787
(3018418) pH of Serum or Plasma
90
526
2.23
7.34
4.9
4.2
ph
7.4
7.4
0.68
15
96
(3015377) Calcium [Moles/volume] in Serum or Plasma
97
587
2.20
7.24
4.1
3.5
mmol/l
2.4
2.4
0.18
88
512
(3016018) Differential panel - Cerebral spinal fluid
10
13
8.02
7.18
1.0
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
107
677
2.17
7.09
2.5
2.2
nmol/l
78.6
76.7
0.29
95
596
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
73
399
2.26
6.94
2.6
2.0
mg/l
2.5
3.4
3.23
64
340
(40760888) Immunoglobulin light chains.free panel - Serum
16
36
4.72
6.83
3.7
4.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
154
1136
2.28
6.78
5.4
4.3
—
398.8
—
0
19
(3006504) Eosinophils/100 leukocytes in Blood
120
805
2.12
6.71
7.1
5.3
%
2.6
2.8
0.43
114
742
(4027681)
11
9
12.80
6.66
1.3
1.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
120
809
2.11
6.58
7.4
5.7
%
8.6
8.6
0.06
115
754
(3022096) Basophils/100 leukocytes in Blood
117
782
2.10
6.56
7.1
5.3
%
0.7
0.7
0.10
112
721
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
134
945
2.13
6.48
7.6
6.6
umol/l
10.3
10.8
0.45
129
892
(3002030) Lymphocytes/100 leukocytes in Blood
121
826
2.08
6.33
7.3
5.5
%
25.6
27.4
0.97
115
767
(3032080) INR in Blood by Coagulation assay
107
711
2.01
5.90
9.1
8.6
inr
1.2
1.2
0.06
31
205
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
32
4.61
5.86
1.1
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
32
4.61
5.86
1.1
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
43
200
2.44
5.82
1.8
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
42
194
2.45
5.77
1.6
3.0
%
1.6
1.9
1.29
37
179
(3019309) Folate [Moles/volume] in Red Blood Cells
60
326
2.17
5.65
1.7
1.7
nmol/l
1038.4
1239.2
0.90
51
241
(3023419) Bacteria identified in Sputum by Culture
11
21
5.47
5.58
2.7
2.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
106
712
1.97
5.57
3.5
2.5
ug/l
124.1
127.9
0.06
100
644
(3021960) Folate [Moles/volume] in Serum or Plasma
72
425
2.05
5.43
2.0
1.6
nmol/l
19.8
21.0
0.31
65
356
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
40
186
2.42
5.40
2.0
5.2
u/l
249.9
245.2
0.08
35
176
(36660697) Celiac disease serology panel - Serum
31
128
2.66
5.34
1.1
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
64
365
2.08
5.28
1.8
1.7
mg/l
0.9
1.3
0.73
44
292
(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum
5
0
+∞
5.23
1.0
0.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
164
1303
2.12
5.12
5.8
4.1
mm/h
13.3
12.1
0.48
156
1187
(3016879) Cocaine [Presence] in Urine
14
36
4.09
5.07
1.6
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
77
480
1.95
4.90
5.5
4.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
53
289
2.11
4.88
1.9
1.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
20
5.20
4.82
1.4
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
35
162
2.39
4.76
2.7
2.3
u/l
90.4
29.9
0.47
27
137
(3037756) Immunofixation for Serum or Plasma
14
38
3.87
4.73
1.4
1.5
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
32
143
2.46
4.69
5.1
6.7
mmol/l
8.5
9.5
0.38
32
136
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
41
205
2.24
4.67
1.8
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
150
1176
1.93
4.57
3.8
3.0
u/l
57.5
45.9
0.59
141
1102
(3000764) Benzodiazepines [Presence] in Urine
14
39
3.77
4.57
1.6
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
14
39
3.77
4.57
1.6
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
14
39
3.77
4.57
1.6
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
32
145
2.42
4.55
1.8
3.3
e9/l
61.2
74.6
2.43
23
118
(3037467) Urinalysis macro (dipstick) panel - Urine
152
1198
1.94
4.54
5.7
4.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
62
370
1.95
4.42
2.5
2.4
e6/l
7.8
4.4
0.92
56
327
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51
284
2.05
4.41
3.8
2.6
e6/l
0.9
0.9
0.06
31
157
(3027944) Amphetamines [Presence] in Urine
14
40
3.68
4.41
1.6
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
17
56
3.21
4.35
1.2
1.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
56
326
1.97
4.27
1.8
1.4
g/l
2.3
2.6
0.36
34
193
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
48
265
2.05
4.24
4.1
2.9
e6/l
3.4
2.4
0.26
28
142
(36304419) Bacteria [Presence] in Urine
73
467
1.86
4.19
4.1
2.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
7
10.28
4.04
1.0
1.0
nmol/l
117.4
151.4
—
7
7
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
86
584
1.79
4.04
4.6
3.3
u/l
33.7
29.9
0.48
81
559
(3030467) Casts [#/volume] in Urine by Automated count
75
489
1.82
4.02
4.2
2.8
e6/l
0.5
0.3
0.58
64
361
(3028707) Methadone [Presence] in Urine by Screen method
9
15
6.21
3.86
1.6
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
79
534
1.76
3.71
4.3
3.0
e6/l
88.9
168.4
0.25
68
418
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
40
3.40
3.69
1.2
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
30
3.81
3.69
1.5
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
99
2.48
3.65
1.3
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
42
233
2.00
3.64
2.5
2.3
%
23.6
22.9
0.10
35
199
(3009261) Glucose [Presence] in Urine by Test strip
116
877
1.71
3.61
3.6
3.7
estimate
0.0
0.0
0.00
19
156
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
14
46
3.19
3.60
1.4
1.3
u/ml
8.6
1.6
—
6
11
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
89
627
1.72
3.58
4.5
3.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
60
379
1.81
3.51
1.7
1.8
pmol/l
413.2
445.5
0.50
53
312
(3021601) Nitrite [Presence] in Urine by Test strip
114
868
1.67
3.38
4.5
4.9
estimate
0.0
0.0
0.00
20
161
(3018095) Leukocytes [#/volume] in Urine
87
617
1.69
3.38
4.9
3.6
e6/l
28.2
80.4
1.50
73
448
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
157
1312
1.75
3.19
3.9
3.9
pmol/l
15.2
14.9
0.69
141
1181
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
183
1605
2.00
3.13
5.3
4.7
mu/l
1.6
1.9
3.01
169
1453
(3000494) Fungus identified in Specimen by Culture
37
208
1.94
3.08
1.9
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
58
376
1.75
3.07
3.3
4.1
kg/l
1.0
1.0
0.21
11
51
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
6
8
7.67
3.07
1.0
1.4
mmol/l
2.0
2.0
—
6
8
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
14
51
2.87
3.05
1.2
2.0
mg/l
1.6
3.9
—
9
35
(3011397) Hemoglobin [Presence] in Urine by Test strip
59
388
1.72
2.96
3.8
3.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
52
332
1.75
2.89
6.0
3.4
ng/l
365.1
143.3
0.47
43
258
(3009508) Creatinine [Moles/volume] in Urine
75
529
1.64
2.89
3.5
3.1
mmol/l
7.9
7.7
0.10
64
432
(3047189) Immunofixation for 24 hour Urine
6
9
6.82
2.88
1.5
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
9
6.82
2.88
1.0
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
54
351
1.72
2.82
2.4
2.7
mosm/kgh2o
458.8
546.3
2.66
48
305
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
22
105
2.22
2.80
1.8
1.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
6
8.49
2.76
1.0
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
6
8.49
2.76
1.0
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
93
698
1.59
2.76
4.9
3.8
ng/l
78.3
38.0
0.39
69
490
(3035350) Ketones [Presence] in Urine by Test strip
110
859
1.58
2.75
3.6
3.7
estimate
0.0
0.0
0.00
20
166
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
10
6.14
2.71
1.7
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
72
510
1.62
2.70
3.6
3.2
mg/l
2880.9
171.8
1.01
46
323
(3000570) Elastase.pancreatic [Mass/mass] in Stool
13
50
2.70
2.58
1.6
1.5
ug/g
306.3
296.5
—
8
26
(3007853) Bacteria identified in Skin by Aerobe culture
35
208
1.82
2.46
2.4
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
62
432
1.61
2.46
8.9
7.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
192
1746
2.01
2.44
23.9
14.0
mg/l
23.3
22.9
0.05
167
1384
(3011288) Drugs identified in Urine by Screen method
9
27
3.43
2.42
1.7
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
27
3.43
2.42
1.0
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
17
4.22
2.38
1.0
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
42
269
1.70
2.29
1.5
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
72
528
1.55
2.28
3.3
2.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
60
2.43
2.27
1.4
1.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
9
5.66
2.22
1.0
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
33
202
1.75
2.11
16.8
7.8
mmol/l
1.9
1.1
0.47
24
158
(1761868) Lipid panel - Serum or Plasma
46
648
0.63
2.04
2.9
3.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
38
2.71
2.04
2.7
2.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
7
172
0.39
2.02
1.4
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
102
822
1.46
2.00
5.2
3.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
45
306
1.60
1.95
1.3
1.3
iu/ml
32.5
36.0
0.09
13
95
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
6
16
3.83
1.95
1.2
1.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
6
16
3.83
1.95
1.5
3.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
21
115
1.92
1.91
4.1
2.3
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
9
35
2.64
1.82
4.3
2.9
kpa
4.8
5.0
—
9
35
(3027315) Oxygen [Partial pressure] in Blood
9
35
2.64
1.82
4.3
2.9
kpa
8.0
8.5
—
9
35
(3003327) Ova and parasites identified in Stool by Light microscopy
13
60
2.24
1.82
1.5
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
13
60
2.24
1.82
1.9
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
21
118
1.86
1.78
2.7
2.2
e9/l
3.8
3.9
0.08
16
92
(3020682) Albumin/Creatinine [Ratio] in Urine
71
544
1.46
1.77
4.4
4.0
mg/mmol
12.6
7.5
0.40
43
337
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
185
1701
1.67
1.75
4.8
4.7
mmol/l
6.2
6.0
0.73
173
1546
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
42
2.45
1.70
1.0
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
13
62
2.17
1.69
1.5
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
19
3.22
1.67
1.7
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
7
25
2.86
1.66
1.4
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
15
77
2.02
1.63
1.9
3.7
mmol/l
25.0
24.1
0.57
15
68
(3044889) 12 lead EKG panel
141
1234
1.42
1.63
4.2
4.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
93
758
1.40
1.63
10.2
9.4
e9/l
0.0
0.0
1.29
75
612
(40768797) Stomach Pathology biopsy report
34
226
1.60
1.62
1.2
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
62
471
1.45
1.60
2.0
2.9
umol/l
329.2
8573.1
2.44
55
401
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
23
138
1.75
1.59
3.1
3.0
ml/min/173m2
56.1
60.6
—
9
60
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
26
2.75
1.59
1.1
1.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
8
33
2.48
1.55
1.1
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
14
72
2.01
1.52
3.5
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
12
58
2.13
1.52
3.7
2.4
—
—
—
0
0
(3012544) pH of Venous blood
26
164
1.67
1.52
3.0
4.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
57
431
1.44
1.50
3.2
2.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
197
1857
1.81
1.49
28.4
16.8
umol/l
74.9
77.7
0.85
197
1857
(3019230) Fractional oxyhemoglobin in Venous blood
7
28
2.55
1.46
1.9
2.0
%
73.1
59.4
—
7
28
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
27
174
1.63
1.46
1.5
1.6
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
25
159
1.65
1.42
2.5
3.9
kpa
5.9
5.7
0.55
25
154
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
121
1046
1.36
1.42
3.4
3.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
40
286
1.49
1.39
1.3
1.3
u/ml
1.1
8.1
2.03
14
103
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
41
2.25
1.39
1.0
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
61
474
1.40
1.37
1.6
1.6
mmol/l
1.5
1.4
0.28
56
387
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
16
90
1.84
1.37
12.5
9.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
20
121
1.72
1.36
20.9
4.5
—
—
—
0
0
(3020891) Body temperature
13
69
1.94
1.31
27.3
3.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
24
2.54
1.31
1.2
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
24
2.54
1.31
1.2
1.2
—
—
—
0
0
(4146454)
5
18
2.82
1.29
3.2
2.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
82
676
1.35
1.27
3.2
3.8
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
25
2.44
1.25
1.2
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
45
2.04
1.25
1.0
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
19
2.67
1.22
1.8
1.9
pg
33.8
33.0
—
5
19
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
19
2.67
1.22
1.0
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
70
567
1.35
1.21
3.2
2.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
38
2.15
1.20
4.3
1.9
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
26
2.34
1.19
1.2
1.7
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
26
2.34
1.19
1.2
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
26
2.34
1.19
1.2
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
26
2.34
1.19
1.2
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
50
2.05
1.18
1.0
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
30
210
1.50
1.16
2.8
1.9
ug/g
100.3
123.5
0.29
24
169
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
20
2.53
1.15
3.4
2.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
15
88
1.76
1.14
5.0
3.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
13
73
1.83
1.13
1.8
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
40
2.04
1.13
1.3
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
171
1587
1.39
1.12
25.4
14.9
%
40.4
40.1
0.23
121
1139
(3042936) Bacteria identified in Isolate by Culture
35
256
1.44
1.10
3.9
1.9
—
—
—
0
0
(3019225) pH of Specimen
24
162
1.54
1.10
5.3
4.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
41
1.99
1.10
1.3
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
21
2.41
1.09
1.2
1.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
32
2.23
1.09
1.1
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7
32
2.23
1.09
1.1
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
50
391
1.36
1.08
4.1
4.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
33
2.16
1.06
2.4
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
22
2.30
1.04
1.0
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
22
2.30
1.04
1.4
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
177
1659
1.40
1.03
21.9
13.2
ml/min/173m2
80.4
79.9
0.10
151
1369
(3024354) Oxygen [Partial pressure] in Venous blood
20
132
1.57
1.01
2.3
2.9
kpa
4.7
4.3
0.38
20
127
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
35
2.03
1.01
1.4
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
19
124
1.58
1.01
2.3
3.9
ng/l
73.8
80.5
0.19
14
108
(3017143) Hepatitis C virus Ab [Presence] in Serum
26
183
1.48
0.99
1.3
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
30
218
1.44
0.98
1.3
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
36
1.98
0.98
1.7
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
9
50
1.83
0.98
1.9
3.8
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
30
219
1.43
0.96
4.4
4.5
ug/l
31.0
27.5
0.04
24
178
(3024928) Oxygen saturation in Venous blood
7
37
1.92
0.95
3.7
3.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
18
118
1.57
0.94
1.5
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
27
2.26
0.94
1.2
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
83
712
1.27
0.92
1.9
2.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
42
1.94
0.89
1.1
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
43
1.89
0.88
1.0
1.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
6
30
2.03
0.87
1.0
1.1
—
28.9
—
0
8
(3021879) Hepatitis B virus core Ab [Presence] in Serum
18
121
1.53
0.86
1.3
1.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
15
97
1.59
0.84
9.3
7.5
mmol/l
24.9
25.1
0.05
15
97
(3025941) Bacteria identified in Stool by Culture
15
97
1.59
0.84
1.1
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
20
139
1.48
0.83
6.7
8.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
32
1.90
0.82
1.5
6.7
—
150.5
—
0
6
(3029937) Albumin [Presence] in Urine by Test strip
57
473
1.28
0.82
4.1
4.0
estimate
0.0
0.0
0.00
20
159
(3002256) Pathology report gross observation
29
218
1.38
0.80
1.2
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
192
1842
1.43
0.79
21.0
13.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
58
485
1.27
0.78
2.6
3.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
175
1657
1.31
0.78
6.5
5.9
mmol/mol
40.7
40.2
0.25
168
1541
(3048929) Epstein Barr virus Ab [Presence] in Serum
7
38
1.87
0.74
1.1
1.3
—
—
—
0
0
(3013512) EKG study
62
527
1.25
0.73
4.4
4.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
26
1.94
0.71
1.4
1.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
26
1.94
0.71
1.0
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
41
1.73
0.70
1.7
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
14
94
1.52
0.68
2.2
2.6
%
1.8
1.1
1.31
14
94
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
154
0.63
0.67
1.1
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
44
1.61
0.66
1.0
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
2.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
2.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
2.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
53
453
1.23
0.59
1.3
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
8
53
1.53
0.59
1.5
1.8
mu/l
291.0
317.4
—
8
47
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
23
0.00
0.58
0.0
3.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
55
1.47
0.56
1.1
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
10
65
1.56
0.56
2.4
2.6
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
99
1.44
0.55
1.3
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
157
0.68
0.53
1.6
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
184
1777
1.26
0.51
5.3
5.1
mmol/l
2.6
2.8
1.30
174
1625
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
106
0.65
0.50
1.4
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
93
1.42
0.49
1.0
1.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
45
1.57
0.49
1.1
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
12
85
1.44
0.48
1.3
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
19
147
1.32
0.47
5.1
3.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
54
475
1.18
0.45
3.5
4.6
%
22.0
21.7
0.05
20
227
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
180
1745
1.20
0.40
4.6
4.6
mmol/l
4.5
4.7
1.86
170
1610
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
61
1.32
0.40
2.3
2.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
19
0.00
0.39
0.0
1.9
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
26
216
1.23
0.39
1.3
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
179
1737
1.19
0.38
4.5
4.5
mmol/l
1.4
1.5
1.13
166
1594
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
155
0.76
0.34
3.1
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
91
1.34
0.34
2.3
2.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
6
45
1.34
0.34
1.0
1.1
—
3.4
—
0
7
(3019832) Treponema pallidum Ab [Presence] in Serum
15
119
1.28
0.33
1.3
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
25
212
1.20
0.32
9.1
8.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
7
98
0.70
0.31
3.0
2.9
u/ml
12.6
46.5
—
7
93
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
20
166
1.23
0.31
3.2
3.5
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
7
56
1.26
0.29
47.6
3.5
mmol/l
3.8
3.9
—
7
49
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
65
600
1.12
0.28
4.6
4.9
ug/l
1.7
2.2
0.65
59
535
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
65
1.24
0.27
2.3
2.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
3.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
3.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
10
0.00
0.21
0.0
8.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
5
43
1.17
0.21
1.2
1.2
nmol/l
0.7
0.9
—
5
36
(3044242) Glucose [Moles/volume] in Arterial blood
0
13
0.00
0.21
0.0
6.8
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
13.8
—
2129.8
—
0
13
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
10.2
—
1149.4
—
0
13
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
14
0.00
0.20
0.0
2.4
—
8.4
—
0
9
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
0
14
0.00
0.20
0.0
1.4
—
2.9
—
0
7
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
171
1677
1.10
0.18
4.4
4.1
mmol/l
1.3
1.3
0.22
161
1531
(40761536) Microorganisms panel - Urine sediment
17
148
1.16
0.17
3.9
3.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
12
141
0.84
0.17
2.6
1.7
—
—
—
0
0
(4010399)
16
140
1.15
0.15
1.9
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
90
0.77
0.14
1.0
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
37
348
1.08
0.11
2.7
2.9
ug/l
0.7
0.7
0.18
28
222
(4035726)
19
173
1.11
0.11
1.4
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
44
1.14
0.10
1.8
1.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
6
56
1.07
0.08
1.5
2.3
mg/l
1.8
1.6
—
6
50
(3008898) HLA-B27 [Presence]
5
64
0.78
0.08
1.0
1.1
—
—
—
0
0
(4034850)
7
67
1.05
0.08
9.1
12.1
—
—
—
0
0
(1002224) Polysomnography panel
8
77
1.04
0.07
1.1
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
10
91
1.10
0.04
3.7
4.1
—
—
—
0
0
(3000492) Spirometry study
17
160
1.07
0.04
1.2
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
28
271
1.04
0.02
1.5
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
25
251
1.00
0.00
1.1
1.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
7
0.00
0.00
0.0
9.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
23
230
1.00
0.00
4.9
4.8
%
34.0
31.2
0.44
17
150
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
17.3
—
0
5
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
69
1.01
0.00
1.1
1.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(44806420)
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint G6_PERIPHOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_PERIPHOTH | 1.811 [1.42, 2.32] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.162 |
During the follow-up period (1.1.1998 — 31.12.2019), 143 out of 508 females with G6_PERIPHOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_PERIPHOTH | 2.226 [1.7, 2.91] | < 0.001 |
| Birth year | 0.984 [0.97, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 185 out of 563 males with G6_PERIPHOTH died.
Mortality risk
Mortality risk for people of age
years, who have G6_PERIPHOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.178% | 0.322% |
| 5 | 0.962% | 2.451% |
| 10 | 2.551% | 6.395% |
| 15 | 4.571% | 12.048% |
| 20 | 7.489% | 19.046% |
Relationships between endpoints
↥Index endpoint: G6_PERIPHOTH – Other disorders of peripheral nervous system
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data